| Application no. and date | 17897227.9 (espacenet) (Federated) (European Patent Register), 20170516 | | Patent/reg. no. and date | DK/EP 3426250, 20220323 | | Publication date | 20190116 | | Priority no. and date | | | EP pub. no. and date |
EP 3426250 20190116 | | Effective date | | | Applicant/owner | Bow River LLC, 2012 Seadrift Drive
Corona Del Mar, California 92625, US | | Applicant ref. no. | 1622819 | | Inventor | SRINIVASAN, Sundar, c/o Bow River LLC
2012 Seadrift Drive
Corona Del Mar, California 92625, US,
CHOW, Christina, 325 23rd Ave E
Seattle, WA 98112, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/05 (2006.01) , A61K 31/4178 (2006.01) , A61K 31/44 (2006.01) , A61K 31/4545 (2006.01) , A61K 31/47 (2006.01) , A61K 31/495 (2006.01) , A61K 31/496 (2006.01) , A61K 31/4985 (2006.01) , A61K 31/502 (2006.01) , A61K 31/506 (2006.01) , A61K 31/519 (2006.01) , A61K 31/675 (2006.01) , A61P 25/24 (2006.01) , A61P 35/02 (2006.01) , A61P 35/04 (2006.01) , A61P 9/00 (2006.01) | | Title | BEHANDLING AF EN PATIENT MED ET CYP3A4-SUBSTRATLÆGEMIDDEL, DER ER KONTRAINDICERET TIL ADMINISTRATION SAMMEN MED EN STÆRK CYP3A4-INHIBITOR | | Int. application no. | US2017032924 | | Int. publication no. | WO2018212764 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
